Condition category
Cancer
Date applied
27/02/2018
Date assigned
05/03/2018
Last edited
05/03/2018
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Public awareness of the link between cancer risk and getting older is low. In the United Kingdom, Canada, and Australia, less than 1 in every 7 people asked knew that cancer was most common in those over the age of 70 compared to those younger. This lack of awareness may be linked to poorer cancer survival in these countries due to delay in presentation to a doctor and delay in diagnosis. This study aims to address low awareness of cancer by developing and testing picture-based information resources called 'infographics' that are easier to understand by the public to help make information about cancer more accessible and allow people to make more informed decisions about cancer.

Who can participate?
Adult males aged 50 years or older

What does the study involve?
Participants are randomly allocated into one of three groups.
All participants attend a single supervised appointment that lasts approximately one hour. They complete a short paper-based questionnaire to test awareness of cancer risk. Those in the first group receive an A4 page containing information about cancer risk in different age groups in purely text format (words and numbers only).
Participants in the second group receive this information in purely picture format (an icon array infographic with no text explanation).
Those in the third group receive this information in a mix of text and picture format (a combination of the information found within the other two groups).
All participants have two minutes to view their information then are followed up immediately with the same question from the first questionnaire designed to test awareness of cancer risk in different age groups.

What are the possible benefits and risks of participating?
Benefits of taking part in this study include getting the chance to learn something new about cancer risk and helping in the design of a new evidence-based cancer information resource. Whilst there are no immediate risks to participants taking part in this research study, any participant who is affected by issues brought up by the subject matter is encouraged to speak to researchers at the end of each visit and a General Practitioner is a named contact on participant information leaflets given out prior to each visit.

Where is the study run from?
1. Men’s Shed Steeple Antrim (UK)
2. Men’s Shed fermanagh (UK)
3. Men’s Shed Downpatrick (UK)

When is the study starting and how long is it expected to run for?
April 2017 to November 2017

Who is funding the study?
Queen’s University Belfast (UK)

Who is the main contact?
Dr Alan McCrorie (Scientific)

Trial website

Contact information

Type

Scientific

Primary contact

Dr Alan David McCrorie

ORCID ID

http://orcid.org/0000-0002-7422-2154

Contact details

School of Medicine
Dentistry & Biomedical Sciences
Queen’s University Belfast
Whitla Medical Building
97 Lisburn Road
Belfast
BT9 7BL
United Kingdom

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

17.27V3

Study information

Scientific title

Trial of Infographics in Northern Ireland

Acronym

TINI

Study hypothesis

Pictures (infographics) are superior to text based information for the communication of cancer statistics information

Ethics approval

Queen's University Belfast Medical School Ethics committee, 19/07/2017, ref: 17.27V3

Study design

Single blinded three-armed randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Community

Trial type

Other

Patient information sheet

Not available in web format, please use contact details to request a participant information sheet

Condition

Healthcare knowledge (specifically, knowledge of association between cancer and old age)

Intervention

Participants are randomly allocated to a control group, or one of two intervention groups using block randomisation software.
All participants attend a single supervised appointment that lasts approximately one hour. They receive an A4 size printed black and white paper containing information about cancer risk in different age groups, given to them after answering a short paper-based questionnaire with a validated question embedded within designed to test awareness of cancer risk in different age groups.
Those in the control intervention receive this information in purely text format (words and numbers only).
Intervention group A receive this information in purely picture format (an icon array infographic with no text explanation).
Intervention group B receive this information in a hybrid text and picture format (a combination of the information found within control and intervention A groups).
All participants have two minutes to view their randomly assigned information. Participants are followed up immediately after viewing information with the same question from the questionnaire phase designed to test awareness of cancer risk in different age groups.

Intervention type

Behavioural

Phase

Drug names

Primary outcome measures

Knowledge of association between cancer risk and old age is measured using a question ('over the next year, which of these groups of people, if any, do you think is most likely to be diagnosed with cancer? 30 year olds? 50 year olds? 70 year olds? people of any age are equally likely to be diagnosed with cancer?') from the internationally validated awareness and beliefs about cancer (ABC) questionnaire at baseline and immediately after viewing the information.

Secondary outcome measures

Metrics such as education, numerical literacy, age, and personal experience of cancer are measured using a 16 item questionnaire containing non-calculator numeracy questions from the internationally validated statistical numeracy for health questionnaire and questions from the internationally validated awareness and beliefs about cancer (ABC) questionnaire at baseline.

Overall trial start date

01/04/2017

Overall trial end date

30/11/2017

Reason abandoned

Eligibility

Participant inclusion criteria

1. Males
2. Aged 50 years or above
3. Live in Northern Ireland
4. Consent to participate
5. Speak/read English

Participant type

Other

Age group

Adult

Gender

Male

Target number of participants

30-60 participants

Participant exclusion criteria

1. Females
2. Males under the age of 50
3. People who do not speak or read English

Recruitment start date

19/07/2017

Recruitment end date

31/07/2017

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Men's Shed Steeple Antrim
4a Steeple Road
Antrim
BT41 1AF
United Kingdom

Trial participating centre

Men's Shed Fermanagh
Drumcoo
Enniskillen
BT74 4FY
United Kingdom

Trial participating centre

Men's Shed Downpatrick
3 Ballydugan Industrial Estate
Downpatrick
BT74 4FY
United Kingdom

Trial participating centre

Strabane and Lifford Men's Shed
29 Patrick Street
Strabane
BT82 8DQ
United Kingdom

Sponsor information

Organisation

Queen's University Belfast

Sponsor details

School of Medicine
Dentistry & Biomedical Sciences
Queen’s University Belfast
Whitla Medical Building
97 Lisburn Road
Belfast
BT9 7BL
United Kingdom

Sponsor type

University/education

Website

www.qub.ac.uk

Funders

Funder type

University/education

Funder name

Queen's University Belfast

Alternative name(s)

Funding Body Type

private sector organisation

Funding Body Subtype

academic

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Publication in a peer-reviewed medical journal.

IPD sharing statement:
The datasets generated during and/or analysed during the current study and other documentation associated with this trial are/will be available upon request from Dr Alan McCrorie.

Intention to publish date

01/04/2018

Participant level data

Available on request

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes